Clinical Trial Update: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of TQH2722 Injection for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• TQH2722 Injection (TQH2722)

Snippet

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED